HC Wainwright reiterated their buy rating on shares of Acurx Pharmaceuticals (NASDAQ:ACXP – Get Rating) in a research note issued to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $14.00 price target on the stock. Acurx Pharmaceuticals Price Performance ACXP opened at $2.96 on Tuesday. The firm has a 50 day simple […]